DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Biogen Idec (NASDAQ: BIIB)

309.43 9.40 (3.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $309.43 3.13%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $305.40
Previous Close $300.03
Daily Range $303.76 - $325.00
52-Week Range $290.85 - $480.18
Market Cap $72.8B
P/E Ratio 20.26
Dividend (Yield) $0.00 (0.0%)
Volume 9,964,453
Average Daily Volume 2,083,602
Current FY EPS $16.62




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

5 Things Biogen's Management Wants You to Know

Tecfidera, more Tecfidera, and how to replace Tecfidera growth.

Buy ConocoPhillips When Oil Is At $43 - Cramer's Lightning Round (7/27/15)

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash

With The Teva Money, Allergan Could Engage In 'Large M&A' Next: Evercore ISI

Is the U.S. Bull Market Starting to Lose Its Luster?

Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog

Stock Market News for July 27, 2015 - Market News

Caution Continues In Options Market This Week

3 Signs That the Healthcare Stock Bubble Might Have Just Popped

Should healthcare investors start to move to the sidelines after the disappointing earnings reports from top dogs AbbVie, Biogen, and Illumina?

S&P 500 Movers: MYL, BIIB

See More BIIB News...

BIIB's Top Competitors

BIIB $309.43 (3.13%)
Current stock: BIIB
GILD $110.54 (-2.03%)
Current stock: GILD
AMGN $165.54 (4.38%)
Current stock: AMGN
$0.00 (0.00%)
Current stock: